C12 Glucosyl(beta) Ceramide (d18:1/12:0)
| Catalog Number | BL-M001059 |
| CAS Number | 111956-48-0 |
| Description | C12 Glucosyl(beta) Ceramide (d18:1/12:0) serves as a pivotal lipid compound within the biomedical sector, enabling comprehensive exploration of intricate metabolic cascades, cellular communication mechanisms, and lipid processing pathways. Additionally, its substantial involvement extends to the therapeutic intervention of select neurodegenerative disorders and in-depth investigations within the realm of oncological studies. |
 | |
| IUPAC Name | N-[(E,2S,3R)-3-hydroxy-1-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]dodecanamide |
| Synonyms | D-glucosyl-beta-1,1'-N-lauroyl-D-erythro-sphingosine; C12 beta-D-glucosyl ceramide; N-(dodecanoyl)-1-beta-glucosyl-sphing-4-enine; Dodecanamide, N-[1-[(beta-D-glucopyranosyloxy)methyl]-2-hydroxy-3-heptadecen-1-yl]- |
| Molecular Weight | 643.94 |
| Molecular Formula | C36H69NO8 |
| Boiling Point | 813.0±65.0 °C at 760 mmHg |
| Purity | >99% |
| Density | 1.1±0.1 g/cm3 |
| Appearance | Powder |
| Shelf Life | 1 Year |
| Storage | Store at -20°C |
| Percent Composition | C 67.15%, H 10.80%, N 2.18%, O 19.88% |
| Canonical SMILES | CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCCCCCC)O |
| InChI | InChI=1S/C36H69NO8/c1-3-5-7-9-11-13-14-15-16-18-19-21-23-25-30(39)29(28-44-36-35(43)34(42)33(41)31(27-38)45-36)37-32(40)26-24-22-20-17-12-10-8-6-4-2/h23,25,29-31,33-36,38-39,41-43H,3-22,24,26-28H2,1-2H3,(H,37,40)/b25-23+/t29-,30+,31?,33+,34?,35?,36+/m0/s1 |
| InChI Key | IYCYEZLMOLRFAN-QGJHTTTBSA-N |
※ Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Related Products
Online Inquiry
